Vasoplegia in Cardiac Surgery and Mechanical Circulatory Support: From Cardiopulmonary Bypass to Advanced Circulatory Support Devices
Journal of Cardiovascular Development and Disease · 10.08.2026 · 13 (8) · 378
DOI: 10.3390/jcdd13080378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 10.08.2026. Verfasst von Debora Emanuela Torre und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Anesthesia and Intensive Care Unit, Cardiac Surgery, Ospedale dell'Angelo, 30174 Venice, Italy. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vasoplegia remains one of the most challenging and incompletely understood complications across the spectrum of mechanical circulatory support (MCS). Initially described following cardiopulmonary bypass, it is increasingly recognized in patients supported with veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and combined unloading strategies such as ECPELLA (ECMO and Impella support) as well as in patients bridged to heart transplantation with temporary or durable mechanical circulatory support (MCS). Despite occurring in different clinical settings, these syndromes share common pathophysiological features, including systemic inflammation, endothelial dysfunction, glycocalyx degradation, dysregulated nitric oxide signaling, neurohormonal imbalance, microcirculatory impairment and severe vasomotor dysregulation. Although vasoplegia is commonly considered a technology-specific complication, growing evidence suggests that CPB-associated vasoplegia, postcardiotomy vasoplegic syndrome, ECMO-related vasodilatory shock and distributive shock during ECPELLA may represent distinct manifestations of a common pathobiological process driven by blood–artificial surface interactions, ischemia–reperfusion injury, hemolysis and immune activation. This narrative review proposes a unified framework of vasoplegia across the continuum of MCS. Key mechanistic pathways and current therapeutic strategies, including catecholamines, vasopressin, angiotensin II, methylene blue and hydroxocobalamin, are discussed. By integrating evidence from cardiac surgery, critical care and mechanical circulatory support, vasoplegia is presented as a unifying syndrome of extracorporeal circulation. This perspective may support earlier recognition, phenotype-based management and the development of more targeted therapeutic strategies in a clinically significant yet underexplored area of cardiovascular critical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Anesthesia and Intensive Care Unit, Cardiac Surgery, Ospedale dell'Angelo, 30174 Venice, Italy.
- Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padua, Italy.
ORCID-Profile: Debora Emanuela Torre, Carmelo Pirri
Zitieren
APA
Torre, D. E., & Pirri, C. (2026). Vasoplegia in Cardiac Surgery and Mechanical Circulatory Support: From Cardiopulmonary Bypass to Advanced Circulatory Support Devices. Journal of Cardiovascular Development and Disease, 13(8), 378. https://doi.org/10.3390/jcdd13080378
Vancouver
Torre DE, Pirri C. Vasoplegia in Cardiac Surgery and Mechanical Circulatory Support: From Cardiopulmonary Bypass to Advanced Circulatory Support Devices. Journal of Cardiovascular Development and Disease. 2026;13(8):378. doi:10.3390/jcdd13080378
BibTeX
@article{Torre2026,
author = {Torre, Debora Emanuela and Pirri, Carmelo},
title = {Vasoplegia in Cardiac Surgery and Mechanical Circulatory Support: From Cardiopulmonary Bypass to Advanced Circulatory Support Devices},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {8},
pages = {378},
doi = {10.3390/jcdd13080378}
}
EUVIMED